Putting Natural Killer Cells to the Test in Cancer Immunotherapy
A growing number of researchers are testing the potential role of natural killer cells—”NK cells”—in cancer immunotherapy.
A growing number of researchers are testing the potential role of natural killer cells—”NK cells”—in cancer immunotherapy.
Eli Morse has had to make major changes to his active lifestyle, but one thing has stayed the same: Eli and his family will continue to fight his aplastic anemia together.
Through his cutting-edge research, oncologist Brian Wolpin, MD, MPH, is striving to broaden the treatment options available for patients with pancreatic cancer.
Can marijuana control or cure cancer? Can it help with the side effects of treatment? We dive into these common questions and more.
A study by Dana-Farber scientists and an international team of researchers could lead to better treatments for patients with smoldering multiple myeloma, a condition that often precedes myeloma.
With the advent of better treatments, more young patients treated for childhood cancers are surviving longer, and many reach the age when they consider starting families.
Although it is a recognizable cancer in name, there are still many different myths and misconceptions about leukemia. We discuss some of the most common ones.
The differences between cancers in adults and children go well beyond age. In many respects, they are markedly different diseases.
Ever since she was diagnosed with a form of aggressive breast cancer six years ago, Tara Shuman has channeled her abundant energy and optimism into getting through and beyond her cancer, and also on doing everything possible to help others facing it.
Here’s what you should know about what to look out for.
Twenty-five years ago, research nurse Stephanie Morrissey met a man named Tom through a fellow nurse and friend. Tom proposed to her in a patient’s room—and today, they have three children.
Scientists at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) have identified biomarkers in melanoma that could help tailor immunotherapy treatments to maximize the benefits for patients while reducing the likelihood of severe side effects.
Here’s what you should know about confusion—when it’s a symptom or side effect of a brain tumor, when it’s not, and what you can do to mitigate the problem.
Patients whose breast cancer is fueled by the hormones estrogen or progesterone are often treated with therapies that cut off or reduce the body’s supply of these hormones.
A recent discovery about prostate cancer suggests potential new targeted therapeutic strategies for this disease.
Brain tumors are some of the most complex types of cancers that exist. Here, we break down the most common myths and misconceptions surrounding them.
A clinical trial at Dana-Farber has kept Sharon DeCosta’s stage IV metastatic breast cancer stabilized for three years, allowing her a full life of traveling and doting on her three young grandchildren, with a fourth due in December.
Cascade testing is an efficient way of tracking inherited cancer predisposition mutations in families. It can save lives and improve health and overall quality of life.
The evidence to date points to a benefit from reducing or eliminating nighttime eating. But it is too soon to recommend altering meal times for cancer prevention.
The news of a cancer diagnosis can be overwhelming and shocking. A Dana-Farber doctor offers five tips on what patients and caregivers can do after that diagnosis.